Dermatology

Login Register

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Home

Oxford University

Tag: Oxford University

Read all Latest Updates on and about Oxford University

Oxford University is a collegiate research university in Oxford, England. It is the oldest university in the English-speaking world and the world's second-oldest university in continuous operation.

SII ships first set of R21/Matrix-M Malaria Vaccine doses to Africa

Ruchika Sharma21 May 2024 12:30 PM IST

Pune: Serum Institute of India, the world's largest manufacturer of vaccines by number of doses, on Monday shipped its first set of R21/Matrix-M...

University of Oxford scientists launch first human vaccine trials for deadly Nipah virus

Ruchika Sharma16 Jan 2024 11:43 AM IST

UK: Scientists at the University of Oxford in the UK have launched first-in-human vaccine trials for the deadly Nipah virus which impacts many...

BioNTech malaria vaccine study placed on clinical hold by USFDA

WHO adds SII-Oxford University Malaria vaccine to its list of prequalified vaccines

Ruchika Sharma23 Dec 2023 3:00 PM IST

The prequalification of the world's second malaria vaccine, developed by Oxford University and manufactured by Serum Institute of India, is poised to...

Serum Institute-Oxford University malaria vaccine bags WHO recommendation

Ruchika Sharma3 Oct 2023 12:30 PM IST

The R21/Matrix-M malaria vaccine is an easily deployable vaccine that can be manufactured at mass scale and modest cost, enabling as many as hundreds...

SII in talks on fill finishing Oxford University R21 malaria vaccine in Ghana: Expert

Ruchika Sharma21 April 2023 1:15 PM IST

Bengaluru: Vaccine manufacturer Serum Institute of India is holding talks on fill-finishing Oxford University's R21 malaria vaccine in Ghana, which...

University of Oxford Malaria vaccine gets regulatory clearance for use in Ghana

Ruchika Sharma14 April 2023 12:07 PM IST

The vaccine has been approved for use in children aged 5 to 36 months, the age group at highest risk of death from malaria.

DCGI allows Serum Institute to export Ebola vaccine to Uganda

Ruchika Sharma9 Dec 2022 12:15 PM IST

The approval for export comes after an application was submitted to the Drugs Controller General of India by Prakash Kumar Singh, Director, Serum...

Serum Institute of India plans to manufacture Ebola vaccine for use in Uganda outbreak

Ruchika Sharma19 Oct 2022 2:30 PM IST

The source said the Ebola vaccine doses would be supplied free of cost.

AstraZeneca gets USFDA approval for perioperative Imfinzi for bladder cancer

Setback: AstraZeneca nasal spray COVID vaccine fails in early trial

Ruchika Sharma11 Oct 2022 3:33 PM IST

The immune response measured in the blood was weaker than that from a shot-in-the-arm vaccination.

Serum Institute of India gets DCGI nod for export of malaria vaccine to UK

Ruchika Sharma30 Sept 2022 12:15 PM IST

The malaria vaccine was designed at the Jenner Institute, University of Oxford, which collaborated with the SII in 2020 to manufacture and develop the...

AstraZeneca beats US shareholder lawsuit over COVID vaccine disclosures

Ruchika Sharma13 Sept 2022 4:00 PM IST

US District Judge Paul Oetken said AstraZeneca and its executives had no "generalized duty" to disclose "negative facts" about the trials.

COVID 19 can cause brain shrinkage, memory loss study

Roshni Dhar9 March 2022 6:39 PM IST

COVID-19 new complications to cause the brain to shrink, lessen gray matter in the regions that control emotion and memory, and damage areas that...

Journal Club Today

Health News Today

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok